메뉴 건너뛰기
Therapeutic Advances in Medical Oncology
Volumn 3, Issue 5, 2011, Pages 223-227
Advancing breast cancer therapy by translational research: Highlights of the Improving Care and Knowledge through Translational Research (IMPAKT) breast cancer conference
Author keywords

[No Author keywords available]
Indexed keywords

CELECOXIB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MOLECULAR MARKER;
EID: 80054862783     PISSN: 17588340     EISSN: 17588359     Source Type: Journal    
DOI: 10.1177/1758834011413003     Document Type: Editorial
Times cited : (2)
References (6)
  • 1
    • 84993701175 scopus 로고    scopus 로고
    • Circulating tumor cells and Cyfra 2-1 as outcome-associated biomarkers in first-line metastatic breast cancer, results of the IC 2006-04 study
    • Bidard F. Hajage D. Bachelot T. André F. Brain E.G. Campone M. et al (2011) Circulating tumor cells and Cyfra 2-1 as outcome-associated biomarkers in first-line metastatic breast cancer, results of the IC 2006-04 study. Ann Oncol 22(Suppl 2): ii41–ii41.
    • (2011) Ann Oncol , vol.22 , Issue.Suppl 2 , pp. ii41-ii41
    • Bidard, F.1    Hajage, D.2    Bachelot, T.3    André, F.4    Brain, E.G.5    Campone, M.6
  • 3
    • 80054873261 scopus 로고    scopus 로고
    • The wnt signaling cascade as a potential biomarker of triple-negative breast cancer (TNBC)
    • Huelsewig C. Ruckert C. Goette M. von Wahlde M.K. Buchweitz O. Kiesel L. et al (2011) The wnt signaling cascade as a potential biomarker of triple-negative breast cancer (TNBC). Ann Oncol 22(Suppl 2): ii51–ii51.
    • (2011) Ann Oncol , vol.22 , Issue.Suppl 2 , pp. ii51-ii51
    • Huelsewig, C.1    Ruckert, C.2    Goette, M.3    von Wahlde, M.K.4    Buchweitz, O.5    Kiesel, L.6
  • 4
    • 80054848576 scopus 로고    scopus 로고
    • Concordance between the 21 gene assay (OncotypeDX®) and the PAM 50 intrinsic classifier for prognosis in early stage ER-positive breast cancer
    • Kelly C.M. Bernard P.S. Krishnamurthy S. Ebbert M.T.W. Bastien R.R.L. Boucher K. et al (2011) Concordance between the 21 gene assay (OncotypeDX®)and the PAM 50 intrinsic classifier for prognosis in early stage ER-positive breast cancer. Ann Oncol 22(Suppl 2): ii44–ii44.
    • (2011) Ann Oncol , vol.22 , Issue.Suppl 2 , pp. ii44-ii44
    • Kelly, C.M.1    Bernard, P.S.2    Krishnamurthy, S.3    Ebbert, M.T.W.4    Bastien, R.R.L.5    Boucher, K.6
  • 5
    • 80054858879 scopus 로고    scopus 로고
    • Combining protein interaction and gene profiling methods for predicting lapatinib response
    • Patel G. Lawler K. Weitsman G. Fruhwirth G. Woodman N. Gillett C. et al (2011) Combining protein interaction and gene profiling methods for predicting lapatinib response. Ann Oncol 22(Suppl 2): ii43–ii43.
    • (2011) Ann Oncol , vol.22 , Issue.Suppl 2 , pp. ii43-ii43
    • Patel, G.1    Lawler, K.2    Weitsman, G.3    Fruhwirth, G.4    Woodman, N.5    Gillett, C.6
  • 6
    • 84993809713 scopus 로고    scopus 로고
    • A randomized trial of pre-operative celecoxib treatment reveals anti-tumor transcriptional response in primary breast cancer
    • Veeck J. Brandao R.D. van Elssen J.C. van de Vijver K.K. Lindsey P.J. Blok M.J. et al (2011) A randomized trial of pre-operative celecoxib treatment reveals anti-tumor transcriptional response in primary breast cancer. Ann Oncol 22(Suppl 2): ii44–ii44.
    • (2011) Ann Oncol , vol.22 , Issue.Suppl 2 , pp. ii44-ii44
    • Veeck, J.1    Brandao, R.D.2    van Elssen, J.C.3    van de Vijver, K.K.4    Lindsey, P.J.5    Blok, M.J.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.